KairoRx review
KairoRx offers clinician-reviewed weight treatment and a separate AI health-advisor feature. Its branded-drug access fees are distinct from the medication bill.
The verdict
KairoRx describes provider messaging and personalized dose review, useful features to verify before starting care. Its AI advisor should not be mistaken for the treating clinician. If a brand is proposed, the quoted access fee does not include the pharmacy’s drug cost.
Disclosure: This GLP is reader-supported. Some links below are affiliate links — if you start care through them we may earn a commission, at no extra cost to you. The order on this page is not commercial, and a commission never changes what we write about a provider. How we make money.
- Category
- GLP-1 telehealth
- Molecule
- Semaglutide · Tirzepatide
- Form
- Injection
- Prescription
- Required
- Compounded
- Yes — not FDA-approved
KairoRx arranges telehealth and pharmacy access for several prescription services, including semaglutide and tirzepatide weight care. Some offers are compounded, while branded listings use a separate access-fee model.
Who writes the prescription, and what do they see?
The terms say KairoRx is neither the medical practice nor the pharmacy. Licensed providers independently determine whether treatment is appropriate, with charging described as occurring after approval. Ask which practice will manage your ongoing prescription.
The process includes online consultation, pharmacy fulfillment and messaging between visits. Baseline and ongoing laboratory guidance are advertised without establishing that every test is free. The AI advisor is an additional interface, not evidence of physician review of each answer.
What happens when the dose goes up?
Personalized dosing and titration support are listed among the service features. Ask who authorizes each adjustment and whether the selected therapy’s price changes as treatment progresses. A starting-price table does not establish every later-strength cost.
What the price includes
The pricing page distinguishes discounted first months from subsequent semaglutide and tirzepatide amounts. For Ozempic and Zepbound, the listed charge is an access fee with medication billed separately. Several therapies vary by dose, so confirm your prescription-specific continuation quote.
What it claims, and what it cites
Both compounded and brand-name GLP-1 options are advertised. Compounded preparations are not FDA approved. Confirm the medicine, formulation and pharmacy on the clinical proposal rather than assuming an access-fee listing buys a particular quantity of branded medication.
Where it holds up, and where it does not
- Strength: Platform and clinical roles distinguished
- Strength: Provider messaging described
- Strength: Branded medication cost separated from access fee
- Limitation: AI feature is not clinical oversight
- Limitation: Some pricing depends on dose
- Limitation: Testing costs not fully established
What the evidence says about this kind of treatment
The assessment above is about KairoRx. These are about the drugs it sells, and they are traced to the primary literature.
- Right for
- Someone who wants online clinical messaging and can distinguish the prescription plan from optional digital advice.
- Wrong for
- A patient interpreting an AI response or a low access fee as a complete branded-drug treatment plan.
The evidence behind what KairoRx prescribes
These studies examine the medicines, not this provider. Results with approved products do not establish the quality or effectiveness of a seller’s compounded formulation.
- Cochrane Review of Semaglutide for Obesity: 18 Trials Graded
A 2025 Cochrane review pooled eighteen randomized trials. The weight figure is high certainty and smaller than the marketing, and almost everything else is graded lower.
- Tirzepatide vs Semaglutide: Which Works Better for Weight Loss?
In a 72-week randomized trial at weight-management doses, weight fell 20.2 percent on tirzepatide and 13.7 percent on semaglutide. Routine-care studies found a smaller gap, three to four points.
How KairoRx compares
| Seller | Who it suits | Go |
|---|---|---|
| SkinnyRx | Readers choosing tirzepatide, the one line with a published standing rate | See SkinnyRx → |
| ShedRx | Readers willing to telephone a seller and ask which published fee is the real one | See ShedRx → |
| RxSpan MD | Buyers who want the standing rate, the pharmacy and the prescriber named before signing up | See RxSpan MD → |
More GLP-1 telehealth sellers reviews: MaxLifeMDExamMeasuredMedi-WeightlossMediRXMedLeanRx
Sponsored alternative
SkinnyRx
Readers choosing tirzepatide, the one line with a published standing rate
Check SkinnyRx availability →Frequently asked
- Does the branded access fee buy the medication?
- No. The pricing page says brand-name medication is billed separately.
- Is the AI advisor the prescribing clinician?
- No. Treatment decisions require a licensed provider’s consultation and independent assessment.
Sources for this review
Provider information checked . Terms can change.